These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

465 related articles for article (PubMed ID: 19844187)

  • 1. Epidermal growth factor receptor mutation and pathologic-radiologic correlation between multiple lung nodules with ground-glass opacity differentiates multicentric origin from intrapulmonary spread.
    Chung JH; Choe G; Jheon S; Sung SW; Kim TJ; Lee KW; Lee JH; Lee CT
    J Thorac Oncol; 2009 Dec; 4(12):1490-5. PubMed ID: 19844187
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Are there imaging characteristics associated with epidermal growth factor receptor and KRAS mutations in patients with adenocarcinoma of the lung with bronchioloalveolar features?
    Glynn C; Zakowski MF; Ginsberg MS
    J Thorac Oncol; 2010 Mar; 5(3):344-8. PubMed ID: 20087229
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epidermal growth factor receptor mutation and p53 overexpression during the multistage progression of small adenocarcinoma of the lung.
    Yoo SB; Chung JH; Lee HJ; Lee CT; Jheon S; Sung SW
    J Thorac Oncol; 2010 Jul; 5(7):964-9. PubMed ID: 20512074
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ground-glass opacity nodules: histopathology, imaging evaluation, and clinical implications.
    Lee HY; Lee KS
    J Thorac Imaging; 2011 May; 26(2):106-18. PubMed ID: 21508733
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mutations of the epidermal growth factor receptor gene in atypical adenomatous hyperplasia and bronchioloalveolar carcinoma of the lung.
    Yoshida Y; Shibata T; Kokubu A; Tsuta K; Matsuno Y; Kanai Y; Asamura H; Tsuchiya R; Hirohashi S
    Lung Cancer; 2005 Oct; 50(1):1-8. PubMed ID: 15950315
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Disproportionate representation of KRAS gene mutation in atypical adenomatous hyperplasia, but even distribution of EGFR gene mutation from preinvasive to invasive adenocarcinomas.
    Sakamoto H; Shimizu J; Horio Y; Ueda R; Takahashi T; Mitsudomi T; Yatabe Y
    J Pathol; 2007 Jul; 212(3):287-94. PubMed ID: 17534846
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epidermal growth factor receptor mutations in multicentric lung adenocarcinomas and atypical adenomatous hyperplasias.
    Ikeda K; Nomori H; Ohba Y; Shibata H; Mori T; Honda Y; Iyama K; Kobayashi T
    J Thorac Oncol; 2008 May; 3(5):467-71. PubMed ID: 18448997
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A clinicopathological study of resected pulmonary nodules with focal pure ground-glass opacity.
    Ohtsuka T; Watanabe K; Kaji M; Naruke T; Suemasu K
    Eur J Cardiothorac Surg; 2006 Jul; 30(1):160-3. PubMed ID: 16723239
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bronchioloalveolar neoplasia.
    Kitamura H; Okudela K
    Int J Clin Exp Pathol; 2010 Nov; 4(1):97-9. PubMed ID: 21228931
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical, pathological and thin-section CT features of persistent multiple ground-glass opacity nodules: comparison with solitary ground-glass opacity nodule.
    Kim TJ; Goo JM; Lee KW; Park CM; Lee HJ
    Lung Cancer; 2009 May; 64(2):171-8. PubMed ID: 18799230
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Frequency of EGFR and KRAS mutations in Japanese patients with lung adenocarcinoma with features of the mucinous subtype of bronchioloalveolar carcinoma.
    Hata A; Katakami N; Fujita S; Kaji R; Imai Y; Takahashi Y; Nishimura T; Tomii K; Ishihara K
    J Thorac Oncol; 2010 Aug; 5(8):1197-200. PubMed ID: 20661086
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High incidence of EGFR mutations in Korean men smokers with no intratumoral heterogeneity of lung adenocarcinomas: correlation with histologic subtypes, EGFR/TTF-1 expressions, and clinical features.
    Sun PL; Seol H; Lee HJ; Yoo SB; Kim H; Xu X; Jheon S; Lee CT; Lee JS; Chung JH
    J Thorac Oncol; 2012 Feb; 7(2):323-30. PubMed ID: 22237264
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Discrepancy of epidermal growth factor receptor mutation in lung adenocarcinoma presenting as multiple ground-glass opacities.
    Liu M; He WX; Song N; Yang Y; Zhang P; Jiang GN
    Eur J Cardiothorac Surg; 2016 Nov; 50(5):909-913. PubMed ID: 27032467
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular markers and changes of computed tomography appearance in lung adenocarcinoma with ground-glass opacity.
    Yoshida Y; Kokubu A; Suzuki K; Kuribayashi H; Tsuta K; Matsuno Y; Kusumoto M; Kanai Y; Asamura H; Hirohashi S; Shibata T
    Jpn J Clin Oncol; 2007 Dec; 37(12):907-12. PubMed ID: 18089646
    [TBL] [Abstract][Full Text] [Related]  

  • 15. How should we manage small focal pure ground-glass opacity nodules on high-resolution computed tomography? A single institute experience.
    Yamaguchi M; Furuya A; Edagawa M; Taguchi K; Shimamatsu S; Toyokawa G; Toyozawa R; Nosaki K; Hirai F; Seto T; Takenoyama M; Ichinose Y
    Surg Oncol; 2015 Sep; 24(3):258-63. PubMed ID: 26298200
    [TBL] [Abstract][Full Text] [Related]  

  • 16. EGFR mutation status in primary lung adenocarcinomas and corresponding metastatic lesions: discordance in pleural metastases.
    Han HS; Eom DW; Kim JH; Kim KH; Shin HM; An JY; Lee KM; Choe KH; Lee KH; Kim ST; Koo JH; Lee HC; Lee OJ
    Clin Lung Cancer; 2011 Nov; 12(6):380-6. PubMed ID: 21729655
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinicopathology and genetic profile of synchronous multiple small adenocarcinomas: implication for surgical treatment of an uncommon lung malignancy.
    Lin MW; Wu CT; Kuo SW; Chang YL; Yang PC
    Ann Surg Oncol; 2014 Aug; 21(8):2555-62. PubMed ID: 24643899
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A simple inflation method for frozen section diagnosis of minute precancerous lesions of the lung.
    Myung JK; Choe G; Chung DH; Seo JW; Jheon S; Lee CT; Chung JH
    Lung Cancer; 2008 Feb; 59(2):198-202. PubMed ID: 17905468
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular characteristics of bronchioloalveolar carcinoma and adenocarcinoma, bronchioloalveolar carcinoma subtype, predict response to erlotinib.
    Miller VA; Riely GJ; Zakowski MF; Li AR; Patel JD; Heelan RT; Kris MG; Sandler AB; Carbone DP; Tsao A; Herbst RS; Heller G; Ladanyi M; Pao W; Johnson DH
    J Clin Oncol; 2008 Mar; 26(9):1472-8. PubMed ID: 18349398
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genetic evolution of epidermal growth factor receptor in adenocarcinoma with a bronchioloalveolar carcinoma component.
    Zhong WZ; Wu YL; Yang XN; Guo AL; Su J; Zhang XC; Luo DL; Wang Z; Chen HJ; Zhou Q; Xu CR; Qiao GB; Liao RQ; Yang JJ; Mok TS
    Clin Lung Cancer; 2010 May; 11(3):160-8. PubMed ID: 20439191
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.